RE: Heterozygous <i>BRCA1/BRCA2</i> and mismatch repair gene pathogenic variants in children and adolescents with cancer-Reference-Cited by-同舟云学术

RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer

Published:2022-12-10 Issue:2 Volume:115 Page:224-225
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Evans D Gareth¹²^ORCID,Woodward Emma R¹²

Affiliation:

1. North west Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust , Manchester, UK

2. Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary’s Hospital, Manchester University NHS Foundation Trust , Manchester, UK

Funder

NIHR

Manchester Biomedical Research Centre

Cancer Research UK

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djac223/48478889/djac223.pdf

Reference5 articles.

1. Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer;Kratz;J Natl Cancer Inst,2022

2. Breast cancer risk genes - association analysis in more than 113,000 women;Dorling;N Engl J Med,2021

3. A population-based study of genes previously implicated in breast cancer;Hu;N Engl J Med,2021

4. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group;Aronson;J Med Genet,2022

5. The contribution of whole gene deletions and large rearrangements to the mutation spectrum in inherited tumor predisposing syndromes;Smith;Hum Mutat,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test?;Clinical Cancer Research;2024-02-27

2. Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors;Pediatric Blood & Cancer;2023-08-19

3. RE: Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer;JNCI: Journal of the National Cancer Institute;2023-04-02

4. Reply to Li and Colleagues;JNCI: Journal of the National Cancer Institute;2023-04-02

5. Reply to Evans and Woodward;JNCI: Journal of the National Cancer Institute;2022-12-10